Fc-null anti-CTLA-4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis-inducing mishap

MedComm ›› 2024, Vol. 5 ›› Issue (6) : e622

PDF
MedComm ›› 2024, Vol. 5 ›› Issue (6) : e622 DOI: 10.1002/mco2.622
HIGHLIGHT

Fc-null anti-CTLA-4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis-inducing mishap

Author information +
History +
PDF

Cite this article

Download citation ▾
null. Fc-null anti-CTLA-4 antibody: a novel strategy to facilitate cancer immunotherapy by ridding the colitis-inducing mishap. MedComm, 2024, 5(6): e622 DOI:10.1002/mco2.622

登录浏览全文

4963

注册一个新账户 忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within
AI Summary AI Mindmap
PDF

162

Accesses

0

Citation

Detail
Sections
Recommended

AI思维导图

/

〈 〉